Gilead Sciences (France)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (France), France, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
171
Total Open
Publications
91
Total
Citations
3.9K
Open Access
Percentage
53%
Total
Publications
171
Total Open
Publications
91
Total
Citations
3.9K
Breakdown
Publisher Open
35%
Both
13%
Other Platform Open
5%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
19
Hybrid 27%
22
No Guarantees 50%
41
Other Platform Open
Domain 81%
26
Institution 13%
4
Other Internet 13%
4
Preprint 9%
3
Public 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 26 |
Europe PMC | Domain | 13 |
Unknown Repository | Other Internet | 2 |
University of Zurich - Zurich Open Repository and Archive | Institution | 2 |
University of Bristol - Bristol Research | Institution | 2 |
Research Square | Preprint | 2 |
DOI | Other Internet | 2 |
University of Toronto - TSpace | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
University Library Bern - BORIS - Bern Open Repository and Information System | Institution | 1 |